Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Feb. 12, 2024
Abstract
Chronic
kidney
disease
(CKD)
has
historically
been
a
significant
global
health
concern,
profoundly
impacting
both
life
and
well-being.
In
the
process
of
CKD,
with
gradual
loss
renal
function,
incidence
various
life-threatening
complications,
such
as
cardiovascular
diseases,
cerebrovascular
accident,
infection
stroke,
is
also
increasing
rapidly.
Unfortunately,
existing
treatments
exhibit
limited
ability
to
halt
progression
injury
in
emphasizing
urgent
need
delve
into
precise
molecular
mechanisms
governing
occurrence
development
CKD
while
identifying
novel
therapeutic
targets.
Renal
fibrosis,
typical
pathological
feature
plays
pivotal
role
disrupting
normal
structures
function.
Ferroptosis
recently
discovered
iron-dependent
form
cell
death
characterized
by
lipid
peroxide
accumulation.
emerged
potential
key
player
diseases
initiation
organ
fibrosis.
Substantial
evidence
suggests
that
ferroptosis
may
significantly
contribute
intricate
interplay
between
its
progression.
This
review
comprehensively
outlines
relationship
terms
iron
metabolism
peroxidation,
discusses
current
landscape
pharmacological
research
on
ferroptosis,
shedding
light
promising
avenues
for
intervention.
It
further
illustrates
recent
breakthroughs
ferroptosis-related
regulatory
implicated
thereby
providing
new
insights
treatment.
Cell,
Journal Year:
2022,
Volume and Issue:
185(14), P. 2401 - 2421
Published: July 1, 2022
Ferroptosis,
a
form
of
cell
death
driven
by
iron-dependent
lipid
peroxidation,
was
identified
as
distinct
phenomenon
and
named
decade
ago.
Ferroptosis
has
been
implicated
in
broad
set
biological
contexts,
from
development
to
aging,
immunity,
cancer.
This
review
describes
key
regulators
this
within
framework
metabolism,
ROS
biology,
iron
biology.
Key
concepts
major
unanswered
questions
the
ferroptosis
field
are
highlighted.
The
next
promises
yield
further
breakthroughs
mechanisms
governing
additional
ways
harnessing
for
therapeutic
benefit.
Signal Transduction and Targeted Therapy,
Journal Year:
2023,
Volume and Issue:
8(1)
Published: March 17, 2023
Abstract
Chronic
kidney
disease
(CKD)
is
estimated
to
affect
10–14%
of
global
population.
Kidney
fibrosis,
characterized
by
excessive
extracellular
matrix
deposition
leading
scarring,
a
hallmark
manifestation
in
different
progressive
CKD;
However,
at
present
no
antifibrotic
therapies
against
CKD
exist.
fibrosis
identified
tubule
atrophy,
interstitial
chronic
inflammation
and
fibrogenesis,
glomerulosclerosis,
vascular
rarefaction.
Fibrotic
niche,
where
organ
initiates,
complex
interplay
between
injured
parenchyma
(like
tubular
cells)
multiple
non-parenchymal
cell
lineages
(immune
mesenchymal
located
spatially
within
scarring
areas.
Although
the
mechanisms
are
complicated
due
kinds
cells
involved,
with
help
single-cell
technology,
many
key
questions
have
been
explored,
such
as
what
kind
renal
tubules
profibrotic,
myofibroblasts
originate,
which
immune
how
communicate
each
other.
In
addition,
genetics
epigenetics
deeper
that
regulate
fibrosis.
And
reversible
nature
epigenetic
changes
including
DNA
methylation,
RNA
interference,
chromatin
remodeling,
gives
an
opportunity
stop
or
reverse
therapeutic
strategies.
More
marketed
(e.g.,
RAS
blockage,
SGLT2
inhibitors)
developed
delay
progression
recent
years.
Furthermore,
better
understanding
also
favored
discover
biomarkers
fibrotic
injury.
review,
we
update
advances
mechanism
summarize
novel
treatment
for
CKD.
Journal of the American Society of Nephrology,
Journal Year:
2022,
Volume and Issue:
33(3), P. 472 - 486
Published: Jan. 12, 2022
Understanding
nephron
loss
is
a
primary
strategy
for
preventing
CKD
progression.
Death
of
renal
tubular
cells
may
occur
by
apoptosis
during
developmental
and
regenerative
processes.
However,
AKI,
the
transition
AKI
to
CKD,
sepsis-associated
kidney
transplantation
ferroptosis
necroptosis,
two
pathways
associated
with
plasma
membrane
integrity,
kill
cells.
This
necrotic
type
cell
death
an
inflammatory
response,
which
referred
as
necroinflammation.
Importantly,
necroinflammatory
response
that
die
necroptosis
be
fundamentally
different
from
tissue
ferroptosis.
Although
mechanisms
have
recently
been
investigated
in
detail,
propagation
necrosis,
although
described
morphologically,
remains
incompletely
understood.
Here,
we
argue
molecular
switch
downstream
necrosis
determines
regeneration
versus
loss.
Unraveling
details
this
"switch"
must
include
signals
potentially
controlled
cells,
including
stimulation
myofibroblasts
origin
fibrosis.
detail
responses
can
inform
discussion
therapeutic
options.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: July 11, 2022
The
kidney
has
tremendous
capacity
to
repair
after
acute
injury,
however,
pathways
guiding
adaptive
and
fibrotic
are
poorly
understood.
We
developed
a
model
of
regeneration
by
titrating
ischemic
injury
dose.
performed
detailed
biochemical
histological
analysis
profiled
transcriptomic
changes
at
bulk
single-cell
level
(>
110,000
cells)
over
time.
Our
highlights
proximal
tubule
cells
as
key
susceptible
injury.
Adaptive
correlated
with
fatty
acid
oxidation
oxidative
phosphorylation.
identify
specific
maladaptive/profibrotic
cluster
long
ischemia,
which
expresses
proinflammatory
profibrotic
cytokines
myeloid
cell
chemotactic
factors.
Druggability
pyroptosis/ferroptosis
vulnerable
in
these
cells.
Pharmacological
targeting
vivo
pushed
towards
ameliorates
fibrosis.
In
summary,
our
defines
differences
identifies
druggable
for
pharmacological
intervention
prevent
Cells,
Journal Year:
2023,
Volume and Issue:
12(5), P. 804 - 804
Published: March 4, 2023
Ferroptosis
is
a
form
of
regulated
cell
death
that
intricately
linked
to
cellular
metabolism.
In
the
forefront
research
on
ferroptosis,
peroxidation
polyunsaturated
fatty
acids
has
emerged
as
key
driver
oxidative
damage
membranes
leading
death.
Here,
we
review
involvement
(PUFAs),
monounsaturated
(MUFAs),
lipid
remodeling
enzymes
and
in
highlighting
studies
revealing
how
using
multicellular
model
organism
Caenorhabditis
elegans
contributes
understanding
roles
specific
lipids
mediators
ferroptosis.
Journal of the American Society of Nephrology,
Journal Year:
2023,
Volume and Issue:
34(4), P. 554 - 571
Published: Jan. 13, 2023
Significance
Statement
Understanding
the
mechanisms
underlying
adaptive
and
maladaptive
renal
repair
after
AKI
their
long-term
consequences
is
critical
to
kidney
health.
The
authors
used
lineage
tracing
of
cycling
cells
single-nucleus
multiomics
(profiling
transcriptome
chromatin
accessibility)
AKI.
They
demonstrated
that
triggers
a
cell-cycle
response
in
most
epithelial
nonepithelial
cell
types.
also
showed
proinflammatory
proximal
tubule
(PTCs)
persist
until
6
months
post-AKI,
although
they
decreased
abundance
over
time,
part,
through
death.
Single-nucleus
lineage-traced
revealed
regulatory
features
repair.
These
included
activation
state–specific
transcription
factors
cis-regulatory
elements,
effects
PTCs
even
repair,
weeks
injury
event.
Background
proliferative
as
part
an
intrinsic
cellular
program,
which
can
lead
restoring
structure
function,
or
with
persistence
injured
altered
structure.
However,
molecular
understanding
these
programs
limited.
Methods
To
examine
transcriptional
responses
same
upon
ischemia-reperfusion
(IRI),
we
combined
genetic
fate
mapping
(
Ki67
+
)
labeled
early
IRI
multiomics—profiling
accessibility
nucleus—and
generated
dataset
83,315
nuclei.
Results
triggered
broad
cycle
preceded
by
type–specific
global
changes
nephron,
collecting
vascular
systems,
stromal
immune
We
observed
heterogeneous
population
throughout
segments
marked
loss
from
4
months.
Gene
expression
profiling
nuclei
highlighted
differences
between
activity
elements
factors,
accompanied
corresponding
target
gene
expression.
Adaptive
was
associated
reduced
genes
encoding
transmembrane
transport
proteins
essential
function.
Conclusions
Analysis
genome
organization
single-cell
resolution
using
offers
new
insight
into
regulation
Weeks
mild-to-moderate
IRI,
aberrant
epigenetic
landscape,
exhibit
profile
following
Cell Death and Disease,
Journal Year:
2023,
Volume and Issue:
14(7)
Published: July 13, 2023
Abstract
Acute
kidney
injury
(AKI)
is
a
prevalent
pathological
condition
that
characterized
by
precipitous
decline
in
renal
function.
In
recent
years,
growing
body
of
studies
have
demonstrated
maladaptation
following
AKI
results
chronic
disease
(CKD).
Therefore,
targeting
the
transition
to
CKD
displays
excellent
therapeutic
potential.
However,
mechanism
mediated
multifactor,
and
there
still
lack
effective
treatments.
Ferroptosis,
novel
nonapoptotic
form
cell
death,
believed
role
progression.
this
study,
we
retrospectively
examined
history
characteristics
ferroptosis,
summarized
ferroptosis’s
research
progress
CKD,
discussed
how
ferroptosis
participates
regulating
progression
CKD.
Furthermore,
highlighted
limitations
present
projected
future
evolution
ferroptosis.
We
hope
work
will
provide
clues
for
further
contribute
study
targets
prevent
diseases.